Skip to content

Clinical trials

Phase 1/2 Inflammation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 1/2 Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20053
20063
20073
20081
20092
20114
20125
20139
20144
20159
20165
20176
20186
20196
20208
20212
20226
20237
20242
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Unknown status15
Recruiting10
Terminated8
Withdrawn7
Active, not recruiting4
Not yet recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lund University3
Fast Forward Pharmaceuticals2
Kristianstad University2
Novartis2
Ohio State University2
University of California, Los Angeles2
University of Florida2
University of Oslo2
University of Oxford2
University of Sao Paulo General Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation103
Alzheimer Disease4
Cardiovascular Diseases4
Metabolic Syndrome4
Pain4
Atherosclerosis3
Autoimmune Diseases3
Diabetes Mellitus, Type 23
HIV Infections3
Heart Failure3

Trials

Showing 51 to 75 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.